Find work in Canada.

A simpler way to find your next job.

Jobs near Edmonton, AB

6 jobs

Within 25 km, plus remote jobs

Email me new jobsSave this search
  • Indigenous Clinical Trials Operations and Partnerships Specialist

    University of Alberta

    Edmonton, AB

    • Full-time

    Proficiency with common office and collaboration tools, with the ability to learn clinical trial, ethics, data and project management systems.

  • Associate Director, CMC, Drug Product

    Xenon Pharmaceuticals

    Remote, Canada

    • $141,800 to $179,300 USD / year
    • Full-time
    • Remote

    …clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2…

  • Associate Director, Quality Control

    Xenon Pharmaceuticals

    Remote, Canada

    • $141,400 to $178,900 CAD / year
    • Full-time
    • Remote

    Lead quality control checks on the CMC sections of regulatory submissions (e.g., Investigational New Drugs (INDs), Clinical Trial Applications (CTAs), and New Drug Applications (NDAs).

  • Clinical Research Associate - Sponsor Dedicated - Bilingual (French/English) Homebased- Quebec,Canada

    Syneos Health

    Remote, Canada

    • Full-time
    • Remote

    …to face meetings. Participates, and may, with supervision, lead, global clinical monitoring/project staff meetings (inclusive of Sponsor representation, as applicable) and attends clinical…

  • Executive Director, Total Rewards

    Xenon Pharmaceuticals

    Remote, Canada

    • $204,200 to $258,300 CAD / year
    • Full-time
    • Remote

    …clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2…

  • Director/Senior Director, CMC, Drug Product Manufacturing (Late Stage/Commercial)

    Xenon Pharmaceuticals

    Remote, Canada

    • $222,300 to $290,900 USD / year
    • Full-time
    • Remote

    …clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2…

No more jobs.